The phosphodiesterase inhibitor rolipram delivered after a spinal cord lesion promotes axonal regeneration and functional recovery

Proceedings of the National Academy of Sciences of the United States of America

Volumn 101, Issue 23, 2004, Pages 8786-8790

  Nikulina, Elena ^a   Tidwell, J Lille ^b   Dai, Hai Ning ^b   Bregman, Barbara S ^b   Filbin, Marie T ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; MYELIN; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; GLIOSIS; MOTOR PERFORMANCE; NERVE CELL CULTURE; NERVE FIBER REGENERATION; NERVE FUNCTION; NERVE GRAFT; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD HEMISECTION; SPINAL CORD INJURY;

ANIMALS; AXONS; CENTRAL NERVOUS SYSTEM AGENTS; CYCLIC AMP; FETAL TISSUE TRANSPLANTATION; NERVE REGENERATION; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, LONG-EVANS; ROLIPRAM; SPINAL CORD; SPINAL CORD INJURIES;

ANIMALIA; MAMMALIA;

EID: 2942558484     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0402595101     Document Type: Article

References (35)

1. Schwab, M. E. & Bartholdi, D. (1996) Physiol. Rev. 76, 319-370.
2. Filbin, M. T. (2003) Nat. Rev. Neurosci. 4, 703-713.
3. Fitch, M. T. & Silver, J. (1999) in CNS Regeneration, eds. Tuszynski, M. H. & Kordower, J. H. (Academic, San Diego), pp. 55-88.
4. Neumann, S., Bradke, F., Tessier-Lavigne, M. & Basbaum, A. I. (2002) Neuron 34, 885-893.
5. Qiu, J., Cai, D., Dai, H., McAtee, M., Hoffman, P. N., Bregman, B. S. & Filbin, M. T. (2002) Neuron 34, 895-903.
6. Spencer, T., Domeniconi, M., Cao, Z. & Filbin, M. T. (2003) Curr. Opin. Neurobiol. 13, 133-139.
7. Domeniconi, M., Cao, Z., Spencer, T., Sivasankaran, R., Wang, R. C., Nikulina, E., Kimura, N., Cai, H., Deng, K., Gao, Y., et al. (2002) Neuron 35, 283-290.
8. Fournier, A. E., GrandPre, T. & Strittmatter, S. M. (2001) Nature 409, 341-346.
9. Liu, B. P., Fournier, A., GrandPre, T. & Strittmatter, S. M. (2002) Science 297, 1190-1193.
10. Wang, K. C., Koprivica, V., Kim, J. A., Sivasankaran, R., Guo, Y., Neve, R. L. & He, Z. (2002) Nature 417, 941-944.
11. Cai, D., Deng, K., Mellado, W., Lee, J., Ratan, R. R. & Filbin, M. T. (2002) Neuron, in press.
12. Krause, W. & Kuhne, G. (1988) Xenobiotica 18, 561-571.
13. Jin, S. L., Richard, F. J., Kuo, W. P., D'Ercole, A. J. & Conti, M. (1999) Proc. Natl. Acad. Sci. USA 96, 11998-12003.
14. Polson, J. B. & Strada, S. J. (1996) Annu. Rev. Pharmacol. Toxicol. 36, 403-427.
15. Raeburn, D. & Advenier, C. (1995) Int. J. Biochem. Cell Biol. 27, 29-37.
16. Mukhopadhyay, G., Doherty, P., Walsh, F. S., Crocker, P. R. & Filbin, M. T. (1994) Neuron 13, 757-767.
17. Cai, D., Shen, Y., De Bellard, M., Tang, S. & Filbin, M. T. (1999) Neuron 22, 89-101.
18. Jones, T. A. & Schallert, T. (1994) J. Neurosci. 14, 2140-2152.
19. Bernstein-Goral, H. & Bregman, B. S. (1993) Exp. Neurol. 123, 118-132.
20. Bregman, B. S., Kunkel-Bagden, E., Reier, P. J., Dai, H. N., McAtee, M. & Gao, D. (1993) Exp. Neurol. 123, 3-16.
21. Coumans, J. V., Lin, T. T., Dai, H. N., MacArthur, L., McAtee, M., Nash, C. & Bregman, B. S. (2001) J. Neurosci. 21, 9334-9344.
22. Buttini, M., Mir, A., Appel, K., Wiederhold, K. H., Limonta, S., Gebicke-Haerter, P. J. & Boddeke, H. W. (1997) Br. J. Pharmacol. 122, 1483-1489.
23. Francischi, J. N., Yokoro, C. M., Poole, S., Tafuri, W. L., Cunha, F. Q. & Teixeira, M. M. (2000) Eur. J. Pharmacol. 399, 243-249.
24. Laemont, K. D., Schaefer, C. J., Juneau, P. L. & Schrier, D. J. (1999) Int. J. Immunopharmacol. 21, 711-725.
25. Haghighi, S. S., Agrawal, S. K., Surdell, D., Jr., Plambeck, R., Agrawal, S., Johnson, G. C. & Walker, A. (2000) Spinal Cord 38, 733-740.
26. Lankhorst, A. J., ter Laak, M. P., Hamers, F. P. & Gispen, W. H. (2000) Brain Res. 859, 334-340.
27. Takami, T., Oudega, M., Bethea, J. R., Wood, P. M., Kleitman, N. & Bunge, M. B. (2002) J. Neurotrauma 19, 653-666.
28. Huang, D. W., McKerracher, L., Braun, P. E. & David, S. (1999) Neuron 24, 639-647.
29. Barad, M., Bourtchouladze, R., Winder, D. G., Golan, H. & Kandel, E. (1998) Proc. Natl. Acad. Sci. USA 95, 15020-15025.
30. Bach, M. E., Barad, M., Son, H., Zhuo, M., Lu, Y. F., Shih, R., Mansuy, I., Hawkins, R. D. & Kandel, E. R. (1999) Proc. Natl. Acad. Sci. USA 96, 5280-5285.
31. Bourtchouladze, R., Lidge, R., Catapano, R., Stanley, J., Gossweiler, S., Romashko, D., Scott, R. & Tully, T. (2003) Proc. Natl. Acad. Sci. USA 100, 10518-10522.
32. Wachtel, H. (1983) Neuropharmacology 22, 267-272.
33. Wachtel, H. & Schneider, H. H. (1986) Neuropharmacology 25, 1119-1126.
34. Hebenstreit, G. F., Fellerer, K., Fichte, K., Fischer, G., Geyer, N., Meya, U., Sastre-y-Hernandez, M., Schony, W., Schratzer, M., Soukop, W., et al. (1989) Pharmacopsychiatry 22, 156-160.
35. Souness, J. E., Aldous, D. & Sargent, C. (2000) Immunopharmacology 47, 127-162.